Diminished brain 5-HT transporter binding in major depression: a positron emission tomography study with [11C]DASB
- First Online:
- Cite this article as:
- Selvaraj, S., Venkatesha Murthy, N., Bhagwagar, Z. et al. Psychopharmacology (2011) 213: 555. doi:10.1007/s00213-009-1660-y
- 224 Downloads
The serotonin transporter (5-HTT) plays a critical role in the regulation of serotonin neurotransmission and has been implicated in the pathophysiology of major depression. In a previous positron emission tomography study, we found no difference in brain 5-HTT binding between unmedicated recovered depressed patients and healthy controls.
This study aims to assess brain 5-HTT binding in a group of unmedicated acutely depressed patients in comparison to healthy controls.
We studied 5-HTT binding using [11C]DASB in conjunction with positron emission tomography in 12 medication-free depressed patients with a mean duration of illness of about 1 year and 24 healthy controls.
The depressed patients had lowered 5-HTT binding in several brain regions including brain stem, thalamus, caudate, putamen, anterior cingulate cortex and frontal cortex.
These results suggest that diminished availability of the 5-HTT in the brain may be a state marker of acute depression. Alternatively, low 5-HTT binding may delineate a group of depressed patients with a poor long-term prognosis.